type here...

CATEGORIES

Pharmaceutics

LATEST

1...567...11Page 6 of 11

TRENDING

EDITORS CHOICE

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

Medika Life -
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Medika Life -
Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

This Is Why We Should NEVER Rush A Vaccine To Market

Dr. Hesham A. Hassaballa -
We need a vaccine for Covid-19. It is a matter of life and death. At the same time, that vaccine has to be proven to be safe and effective

Ivermectin is NOT Hydroxychloroquine. Why is the FDA Ignoring a Potential Covid Treatment?

Robert Turner, Founding Editor -
Ivermectin has shown promise as a potential treatment. It needs to be urgently evaluated under the guidance of the FDA

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories